Spire Healthcare Group (LON:SPI) Sets New 12-Month Low – Here’s What Happened

Spire Healthcare Group plc (LON:SPI) shares reached a new 52-week low during trading on Monday . The company traded as low as GBX 140.80 and last traded at GBX 143, with a volume of 857735 shares changing hands. The stock had previously closed at GBX 142.80.

Spire Healthcare Group Stock Up 2.1%

The company has a debt-to-equity ratio of 177.14, a quick ratio of 0.74 and a current ratio of 0.63. The firm has a market cap of £599.53 million, a price-to-earnings ratio of 32.39, a price-to-earnings-growth ratio of 1.06 and a beta of 0.71. The firm has a 50-day moving average price of GBX 188.99 and a two-hundred day moving average price of GBX 202.34.

Spire Healthcare Group (LON:SPI) last announced its quarterly earnings results on Friday, March 6th. The company reported GBX 9.60 earnings per share (EPS) for the quarter. Spire Healthcare Group had a return on equity of 2.22% and a net margin of 1.04%. On average, sell-side analysts forecast that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current year.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.